{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T11:34:27Z","timestamp":1649072067443},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,8,11]],"date-time":"2013-08-11T00:00:00Z","timestamp":1376179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00277-013-1869-z","type":"journal-article","created":{"date-parts":[[2013,8,10]],"date-time":"2013-08-10T05:36:33Z","timestamp":1376112993000},"page":"713-714","source":"Crossref","is-referenced-by-count":2,"title":["Alemtuzumab induced complete remission of romidepsin-refractory large cell transformation of mycosis fungoides"],"prefix":"10.1007","volume":"93","author":[{"given":"Yok-Lam","family":"Kwong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,11]]},"reference":[{"key":"1869_CR1","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood-2008-05-154609","volume":"112","author":"SO Arulogun","year":"2008","unstructured":"Arulogun SO, Prince HM, Ng J et al (2008) Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation. Blood 112:3082\u20137","journal-title":"Blood"},{"key":"1869_CR2","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2011-08-376319","volume":"119","author":"MF Benner","year":"2012","unstructured":"Benner MF, Jansen PM, Vermeer MH, Willemze R (2012) Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases. Blood 119:1643\u20139","journal-title":"Blood"},{"issue":"25","key":"1869_CR3","first-page":"4997","volume":"121","author":"T Cheng","year":"2013","unstructured":"Cheng T, Loong F, Kwong YL (2013) Positron emission tomography computed tomography in large cell transformation of mycosis fungoides. J Dermatol 121(25):4997\u20135005","journal-title":"J Dermatol"},{"key":"1869_CR4","unstructured":"http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nhl.pdf , pages 94\u2013106. Last accessed April 4, 2013."},{"issue":"32","key":"1869_CR5","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1200\/JCO.2008.21.6150","volume":"27","author":"RL Piekarz","year":"2009","unstructured":"Piekarz RL, Frye R, Turner M et al (2009) Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J Clin Oncol 27(32):5410\u20137","journal-title":"J Clin Oncol"},{"key":"1869_CR6","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1182\/blood-2002-09-2802","volume":"101","author":"J Lundin","year":"2003","unstructured":"Lundin J, Hagberg H, Repp R et al (2003) Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides\/S\u00e9zary syndrome. Blood 101:4267\u20134272","journal-title":"Blood"},{"key":"1869_CR7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1034\/j.1600-0609.2003.00143.x","volume":"71","author":"GA Kennedy","year":"2003","unstructured":"Kennedy GA, Seymour JF, Wolf M et al (2003) Treatment of patients with advanced mycosis fungoides and S\u00e9zary syndrome with alemtuzumab. Eur J Haematol 71:250\u2013256","journal-title":"Eur J Haematol"},{"key":"1869_CR8","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3109\/10428194.2012.659735","volume":"53","author":"SJ Kim","year":"2012","unstructured":"Kim SJ, Moon JH, Kim H et al (2012) Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group. Leuk Lymphoma 53:1515\u201324","journal-title":"Leuk Lymphoma"},{"issue":"117","key":"1869_CR9","doi-asserted-by":"crossref","first-page":"117ra7","DOI":"10.1126\/scitranslmed.3003008","volume":"4","author":"RA Clark","year":"2012","unstructured":"Clark RA, Watanabe R, Teague JE et al (2012) Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients. Sci Transl Med 4(117):117ra7","journal-title":"Sci Transl Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1869-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-013-1869-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1869-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:49:45Z","timestamp":1559036985000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-013-1869-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,11]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1869"],"URL":"https:\/\/doi.org\/10.1007\/s00277-013-1869-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,11]]}}}